2024-01-29 07:56:57 ET
Summary
- Amgen has delivered a 647% total return since 2011 and maintained a solid 10.04% 5-Year Dividend Growth Rate.
- Amid short-term product decisions and sales variations driving down operational efficiency, Amgen's diverse portfolio, global expansion, and strong balance sheet set the stage for sustained future growth.
- Despite concerns about the company's debt and a potentially slowing dividend growth rate, Amgen remains a leader in the biotech sector and top 1% of U.S. Dividend Paying Equities.
...
Read the full article on Seeking Alpha
For further details see:
Amgen: Accelerating The Business And Dividend Growth